Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

AMI Lifesciences is Driven by Chemistry. Powered by People.

Virtual Booth

Ultram ER

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

136 API Suppliers, 36 USDMF, 26 CEP/COS, 7 JDMF, 13 EU WC, 63 KDMF, 19 NDC API, 42 Listed Suppliers, $ API Reference Price

136 API Suppliers
36 USDMF
26 CEP/COS
7 JDMF
13 EU WC
63 KDMF
19 NDC API
42 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

62 Drugs in Development

62 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

800 FDF Dossiers, 83 FDA Orange Book, 417 Europe, 34 Canada, 57 Australia, 58 South Africa, 151 Listed Dossiers

800 FDF Dossiers
83 FDA Orange Book
417 Europe
34 Canada
57 Australia
58 South Africa
151 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 325MG;37.5MG, TABLET, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 100MG, CAPSULE, EXTENDED RELEASE;ORAL - 150MG, CAPSULE, EXTENDED RELEASE;ORAL - 200MG, CAPSULE, EXTENDED RELEASE;ORAL - 300MG

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 325MG;37.5MG
TABLET, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 100MG
CAPSULE, EXTENDED RELEASE;ORAL - 150MG
CAPSULE, EXTENDED RELEASE;ORAL - 200MG
CAPSULE, EXTENDED RELEASE;ORAL - 300MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 6 Evonik, 2 Rochem International Inc, 18 SPI Pharma, 12 DKSH, 1 Pharm-RX Chemical, 11 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 3 Kirsch Pharma, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 34 BASF, 2 CD Formulation, 3 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 12 Gangwal Chemicals, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 22 Roquette, 16 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

1 Minakem
6 Evonik
2 Rochem International Inc
18 SPI Pharma
12 DKSH
1 Pharm-RX Chemical
11 Boai NKY Pharmaceuticals Ltd
7 Gangwal Healthcare
10 Nanjing Well Pharmaceutical
1 Shanghai Minbiotech
1 Pfanstiehl
3 Kirsch Pharma
4 ACG Worldwide
5 Actylis
1 Aeon Procare
2 Alcedo Pharmachem
9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
2 Ashland
1 Avesta Pharma
34 BASF
2 CD Formulation
3 Clariant
11 Corel Pharma Chem
7 DFE Pharma
1 Esteem Industries
2 Finar
12 Gangwal Chemicals
5 Ideal Cures
5 Ingredion Pharma Solutions
26 Kerry
3 Keval Exports
4 Kima Chemical
6 Lonza Capsugel
17 Microlex e.U
1 Nanjing Bold Chemical
3 Nitika Pharmaceutical Specialities
2 Nomisma Healthcare
4 Novo Excipients
5 Pharmatrans-Sanaq
7 Pluviaendo
4 Prachin Chemical
1 Qianhao Chemical (Hebei) Co., Ltd
2 Qualicaps
22 Roquette
16 Seppic
7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
2 Shanghai Welltone Material Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
11 Sigachi Industries
4 Silverline Chemicals
3 The Dow Chemical Company
3 Ulanqab Kema New Material
1 Valens Pharmachem
4 Vasa Pharmachem
1 Vertellus

EXCIPIENTS BY APPLICATIONS

83 Fillers, Diluents & Binders, 58 Coating Systems & Additives, 46 Disintegrants & Superdisintegrants, 44 Direct Compression, 39 Thickeners and Stabilizers, 38 Granulation, 36 Solubilizers, 36 Controlled & Modified Release, 29 Lubricants & Glidants, 28 Topical, 23 Parenteral, 22 Film Formers & Plasticizers, 21 Chewable & Orodispersible Aids, 20 Taste Masking, 16 Co-Processed Excipients, 12 Emulsifying Agents, 10 Rheology Modifiers, 9 Empty Capsules, 9 Surfactant & Foaming Agents, 8 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules

83 Fillers, Diluents & Binders
58 Coating Systems & Additives
46 Disintegrants & Superdisintegrants
44 Direct Compression
39 Thickeners and Stabilizers
38 Granulation
36 Solubilizers
36 Controlled & Modified Release
29 Lubricants & Glidants
28 Topical
23 Parenteral
22 Film Formers & Plasticizers
21 Chewable & Orodispersible Aids
20 Taste Masking
16 Co-Processed Excipients
12 Emulsifying Agents
10 Rheology Modifiers
9 Empty Capsules
9 Surfactant & Foaming Agents
8 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 63 News #PharmaBuzz

1 Data Compilation #PharmaFlow
63 News #PharmaBuzz

GLOBAL SALES INFORMATION

23 US Medicaid Prescriptions, 387 Regulatory FDF Prices

23 US Medicaid Prescriptions
387 Regulatory FDF Prices

MARKET PLACE

60 APIs, 27 FDF Dossiers

60 APIs
27 FDF Dossiers

PATENTS & EXCLUSIVITIES

9 US Patents, 13 Health Canada Patents

9 US Patents
13 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 7 Others

3 EDQM
1 USP
7 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 66 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

7 All

01 2Sigma-Aldrich Corporation

02 2 Aozeal Certified Standards

03 2Clearsynth

04 1Mallinckrodt Pharmaceuticals

filter CAS Number Reset all filters

7 All

01 242036-65-7

02 266170-31-8

03 3Blank

filter Details Reset all filters

7 All

01 1Cat No. CS-O-03639 // Impurity

02 1Cat No. CS-T-07276 // Impurity

03 2In stock

04 3Blank

filter Country Reset all filters

7 All

01 2India

02 1Ireland

03 3U.S.A

04 1Blank

Reset Filter

Price Info

Product Main Page

01

Sigma-Aldrich Corporation

U.S.A

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Tramadol hydrochloride

CAS Number :

Quantity Per Vial :

Sale Unit :

Price : $294.00

Details :

Monograph : PHR8812-200MG

Storage : -10?C to -25?C

Code/Batch No :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Aozeal Certified Standards

U.S.A

iPHEX India

Not Confirmed

Aozeal Certified Standards

U.S.A

iPHEX India

Not Confirmed

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Tramadol HydrochloridE EP Impurity C HCl

CAS Number : 66170-31-8

Quantity Per Vial :

Sale Unit :

Price :

Details : In stock

Monograph :

Storage :

Code/Batch No : T0006.15

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Aozeal Certified Standards

U.S.A

iPHEX India

Not Confirmed

Aozeal Certified Standards

U.S.A

iPHEX India

Not Confirmed

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Tramadol HydrochloridE EP Impurity E HCl

CAS Number : 42036-65-7

Quantity Per Vial :

Sale Unit :

Price :

Details : In stock

Monograph :

Storage :

Code/Batch No : T0006.19

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Clearsynth Labs Limited

India

iPHEX India

Not Confirmed

Clearsynth Labs Limited

India

iPHEX India

Not Confirmed

Post an Enquiry

India

Virtual Booth

Digital Content

Tramadol EP Impurity C Hydrochloride

CAS Number : 66170-31-8

Quantity Per Vial :

Sale Unit :

Price :

Details : Cat No. CS-O-03639 // Impurity

Monograph :

Storage :

Code/Batch No :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Clearsynth Labs Limited

India

iPHEX India

Not Confirmed

Clearsynth Labs Limited

India

iPHEX India

Not Confirmed

Post an Enquiry

India

Virtual Booth

Digital Content

Tramadol EP Impurity E

CAS Number : 42036-65-7

Quantity Per Vial :

Sale Unit :

Price :

Details : Cat No. CS-T-07276 // Impurity

Monograph :

Storage :

Code/Batch No :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Mallinckrodt Pharmaceuticals

Ireland

iPHEX India

Not Confirmed

Mallinckrodt Pharmaceuticals

Ireland

iPHEX India

Not Confirmed

Post an Enquiry

Ireland

Virtual Booth

Digital Content

Tramadol HCl ARS

CAS Number :

Quantity Per Vial :

Sale Unit :

Price :

Details :

Monograph :

Storage :

Code/Batch No : 1119

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

Country

iPHEX India

Not Confirmed

Country

iPHEX India

Not Confirmed

Post an Enquiry

Country

Virtual Booth

Digital Content

CAS Number :

Quantity Per Vial :

Sale Unit :

Price : $294.00

Details :

Monograph : PHR8812-200MG

Storage : -10?C to -25?C

Code/Batch No :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Privacy policy
Terms and conditions
Disclaimers
Ask Us!

Ultram ER

Ultram ER

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

136 API Suppliers

36 USDMF

26 CEP/COS

7 JDMF

13 EU WC

63 KDMF

19 NDC API

42 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

62 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

800 FDF Dossiers

83 FDA Orange Book

417 Europe

34 Canada

57 Australia

58 South Africa

151 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 325MG;37.5MG

TABLET, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 100MG

CAPSULE, EXTENDED RELEASE;ORAL - 150MG

CAPSULE, EXTENDED RELEASE;ORAL - 200MG

CAPSULE, EXTENDED RELEASE;ORAL - 300MG

RELATED EXCIPIENT COMPANIES

1 Minakem

6 Evonik

2 Rochem International Inc

18 SPI Pharma

12 DKSH

1 Pharm-RX Chemical

11 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

10 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Pfanstiehl

3 Kirsch Pharma

4 ACG Worldwide

5 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

1 Avesta Pharma

34 BASF

2 CD Formulation

3 Clariant

11 Corel Pharma Chem

7 DFE Pharma

1 Esteem Industries

2 Finar

12 Gangwal Chemicals

5 Ideal Cures

5 Ingredion Pharma Solutions

26 Kerry

3 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

17 Microlex e.U

1 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

TABLET;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 300MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 300MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons